NEVVI Medicare utilization intelligence
or

← back

Provider profile

KIM, ANGELA DO, MPH

Dermatology · NPI 1649711391 · YUBA CITY, CA

1
Groups
26
Codes · 2024
5,683
Disclosed services

KIM, ANGELA is a Dermatology in YUBA CITY, CA, a member of 1 medical group, who billed 26 distinct codes to Medicare Part B in 2024.

Groups: SUTTER VALLEY MEDICAL FOUNDATION (SACRAMENTO, CA)

Year: 2024 · 2023 · 2022 🔒 · 2021 🔒

Provider overview · all codes · CY2024

5,683
disclosed services
26
codes billed to Medicare Part B
Prior year · CY2023 7,297 disclosed services

This provider's disclosed Medicare payments across all codes were in CY2024.

Dollars, place-of-service mix, business mix and national standing are part of the market analytics platform — built, not launched yet. Notify me at launch →

All figures are disclosed (CMS suppresses fewer-than-11-beneficiary rows) Medicare Part B fee-for-service — a subset, never complete totals; volumes are personal to this NPI, not attributed to any group. Standing is a billed-volume position among specialty peers with disclosed billing (national percentile; a provider's true standing can only be higher, never lower), not a statement about care. See Methods & Sources.

Procedures billed to Medicare Part B (2024)

Medicare Part B FFS · CY2024 · as published by CMS
This provider's Medicare volumes — services, beneficiary-episodes, and charges — are part of the market analytics platform — built, not launched yet. Notify me at launch →
CodeDescription Services Beneficiary-episodes Avg charge Avg Medicare payment
17003 Destruction of precancer skin growth, 2-14 growths
99214 Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more
17000 Destruction of precancer skin growth, 1 growth
99213 Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more
17110 Destruction of skin growth, 1-14 growths
11102 Biopsy of related skin growth, first growth
17004 Destruction of precancer skin growth, 15 or more growths
11103 Biopsy of related skin growth, each additional growth
99204 New patient office or other outpatient visit with moderate level of medical decision making, if using time, 45 minutes or more
J3301 Injection, triamcinolone acetonide, not otherwise specified, 10 mg
99203 New patient office or other outpatient visit with low level of medical decision making, if using time, 30 minutes or more
11900 Injection into skin growth, 1-7 growths
96372 Injection of drug or substance under skin or into muscle
17111 Destruction of skin growth, 15 or more growths
17262 Destruction of cancer skin growth of trunk, arms, or legs, 1.1-2.0 cm
17263 Destruction of cancer skin growth of trunk, arms, or legs, 2.1-3.0 cm
J7308 Aminolevulinic acid hcl for topical administration, 20%, single unit dosage form (354 mg)
12032 Intermediate repair of wound of scalp, underarms, trunk, arms, or legs, 2.6-7.5 cm
11104 Punch biopsy, first skin growth
96574 Application of light with debridement to destroy precancer skin growth
69100 Biopsy of ear
11301 Shaving of skin growth of body, arms, or legs, 0.6-1.0 cm
11603 Removal of cancer skin growth of body, arms, or legs, 2.1-3.0 cm
11200 Removal of skin tag, 1-15 skin tags
11302 Shaving of skin growth of body, arms, or legs, 1.1-2.0 cm
99212 Established patient office or other outpatient visit with straightforward medical decision making, if using time, 10 minutes or more

These are this provider's own Medicare Part B fee-for-service volumes (CMS public data). CMS suppresses rows with fewer than 11 beneficiaries, so low-volume codes may be missing entirely — absence is not zero. Beneficiary-episodes count CMS's per-setting beneficiary figures, not unique patients. Average charge and average Medicare payment are weighted by service volume across office and facility settings. Volumes on this page are personal to the NPI and are not attributed to any physician group. See Methods & Sources.